# BLOODMONEY: Requiem

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

**Measured on 2026-09-18 00:20 UTC.** The whole Steam catalog is re-measured daily; a game that just launched can move a lot between passes.

- Steam appid: 5044390
- Developer: SHROOMYCHRIST Studios
- Released: 2026 · Genre: Simulation · List price: $4.99
- Deal grade: B (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $1.0k to $1.5k per month (mid $1.3k)
- Opportunity score: $2.4k/month at x1.90 dormancy multiplier
- Est. lifetime owners: 1.4k · Est. lifetime net revenue: $2.3k
- Review sentiment: 89% positive across 38 reviews (34 from Steam purchases)
- Review velocity: 30.4 reviews/month (6-month average)

## Why it's flagged

- No developer announcement on record, ever
- Last build shipped 0 months ago
- Store page localized in only 1 language(s)

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $2.3k |
| After VAT / sales tax (-13% blended) | $2.0k |
| After refunds (-9.5% median) | $1.8k |
| Net to developer (after Steam 30%) | $1.3k |

## Estimated acquisition range

$30.5k to $61.0k (2-4x the trailing net annuity of $15.2k/year). Same error range applies.

## Markets by review language

- french: 6% (game NOT localized in this language)
- english: 85% (game NOT localized in this language)
- russian: 3% (game NOT localized in this language)
- spanish: 6% (game NOT localized in this language)

Localization gap: 100% of measured reviews are written in languages the game does not support (top: english). Localizing is likely immediate market expansion.

## Analyst notes (AI-assisted)

_Note written 2026-09-18 from that day's data; the figures in the header are live and supersede any numbers here._

A narrative-driven horror clicker/simulation where players torture a character named Harvey across multiple branching endings, remade with new voice acting and sprite work.

This title occupies an unusual niche: ultra-indie, loyal fanbase across multiple platforms (itch.io originals + Steam port), high review sentiment (89%), and consistent monthly residuals despite minimal marketing spend and zero discounting. The core risk is that it is the third installment in an itch.io franchise with fragmented distribution, and players are asking for closer lore integration with prior entries and standard monetization hooks (achievements, cosmetics). A publisher or studio evaluating back-catalog acquisition should assess whether the IP holder (SHROOMYCHRIST Studios, solo or small team) would consider consolidation, bundling, or live-service expansion; a revival angle is premature given the title shipped recently, but the community clearly wants closure on the Harvey story arc.

- Most realistic play: publishing
- Risk (market): Extremely niche genre (autoclicker + narrative branching) with a very small concurrent player base (29 players now) limits upside and makes discoverability fragile.
- Risk (tech): Multiple reports of progression bugs (Harvey knife fight sequence softlock) and dialogue-subtitle sync issues; small team capacity may limit post-launch support velocity.
- Risk (other): Lore continuity fractured across three separate titles on different platforms; players expect crossover understanding but prior entries remain on itch.io, complicating onboarding.

What players are asking for:
- Steam achievements and cosmetic shop integration to increase engagement hooks
- Explicit ending labels or post-game clarity on which ending was unlocked
- Story closure and lore answers for unresolved character arcs (Harvey's wife, prior game mysteries)
- Consolidated or bundled access to prior Bloodmoney titles for narrative continuity

Suggested first moves:
1. Contact SHROOMYCHRIST Studios to understand studio size, rights clarity, and openness to publishing/consolidation partnerships; confirm IP ownership and any prior itch.io licensing terms.
2. Prioritize a hotfix for the Harvey knife-fight softlock and dialogue sync issues; these are blocking completion and depressing review sentiment despite strong underlying approval.
3. Scope a 'Bloodmoney Complete Edition' bundling all three titles with unified lore glossary and achievement framework; test whether bundled pricing and cross-game achievements unlock new cohort acquisition on Steam.

Generated 2026-09-18 from public signals and player reviews. Directional, not diligence.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier, 40-75x by year. Cohorts from 2020 on are calibrated against 182 sales milestones announced by developers; older ones follow the published Boxleiter tables. Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/5044390
Citation: please cite ResidualPlay (https://residualplay.com) when you publish or quote these estimates.